Share Search
Visit the Share Search
You are here:
Hikma Pharmaceuticals Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Revenue | 2,875.00 | 2,517.00 | 2,553.00 | 2,341.00 | 2,207.00 |
| Operating Profit / Loss | 367.00 | 282.00 | 582.00 | 579.00 | 493.00 |
| Net Interest | -88.00 | -52.00 | -39.00 | -22.00 | n/a |
| Pre Tax Profit | 281.00 | 233.00 | 544.00 | 558.00 | 491.00 |
| Post Tax Profit | 192.00 | 191.00 | 420.00 | 430.00 | 487.00 |
| Profit for the Period | 192.00 | 191.00 | 420.00 | 430.00 | 487.00 |
| Equity Holders of Parent Company | 190.00 | 188.00 | 421.00 | 431.00 | 486.00 |
| Minority Interests | 2.00 | 3.00 | -1.00 | -1.00 | 1.00 |
| Continuing EPS | |||||
| Earnings per Share (Basic) | 86.00 USX | 84.00 USX | 182.30 USX | 182.60 USX | 200.80 USX |
| Earnings per Share (Diluted) | 85.00 USX | 84.00 USX | 180.70 USX | 181.10 USX | 200.00 USX |
| Earnings per Share (Adjusted) | 223.00 USX | 181.00 USX | 194.80 USX | 172.90 USX | 150.40 USX |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | 86.00 USX | 84.00 USX | 182.30 USX | 182.60 USX | 200.80 USX |
| Earnings per Share (Diluted) | 85.00 USX | 84.00 USX | 180.70 USX | 181.10 USX | 200.00 USX |
| Earnings per Share (Adjusted) | 223.00 USX | 181.00 USX | 194.80 USX | 172.90 USX | 150.40 USX |
| Dividend per Share | 0.91 USD | 0.56 USD | 0.54 USD | 0.50 USD | 0.44 USD |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 1,100.00 | 1,124.00 | 892.00 | 876.00 | 834.00 |
| Property, Plant and Equipment | 1,141.00 | 1,081.00 | 1,146.00 | 1,068.00 | 962.00 |
| Investments | 10.00 | 10.00 | 10.00 | 9.00 | 11.00 |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | 103.00 | 65.00 | 47.00 | n/a | n/a |
| Other Non-Current Assets | 226.00 | 192.00 | 183.00 | 260.00 | 275.00 |
| Total Non-Current Assets | 2,580.00 | 2,472.00 | 2,278.00 | 2,213.00 | 2,082.00 |
| Current Assets | |||||
| Inventories | 891.00 | 776.00 | 695.00 | 757.00 | 568.00 |
| Trade and Other Receivables | 873.00 | 841.00 | 876.00 | 756.00 | 719.00 |
| Cash at Bank and in Hand | 205.00 | 270.00 | 426.00 | 323.00 | 442.00 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 131.00 | 112.00 | 97.00 | 86.00 | 119.00 |
| Total Current Assets | 2,100.00 | 1,999.00 | 2,094.00 | 1,922.00 | 1,848.00 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 4,680.00 | 4,471.00 | 4,372.00 | 4,135.00 | 3,930.00 |
| Current Liabilities | |||||
| Borrowings | 161.00 | 148.00 | 121.00 | 168.00 | 578.00 |
| Other Current Liabilities | 1,178.00 | 929.00 | 895.00 | 860.00 | 893.00 |
| Total Current Liabilities | 1,339.00 | 1,077.00 | 1,016.00 | 1,028.00 | 1,471.00 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 1,030.00 | 1,135.00 | 725.00 | 764.00 | 107.00 |
| Provisions | 32.00 | 19.00 | 24.00 | 31.00 | 20.00 |
| Other Non-Current Liabilities | 70.00 | 92.00 | 140.00 | 164.00 | 203.00 |
| Total Non-Current Liabilities | 1,132.00 | 1,246.00 | 889.00 | 959.00 | 330.00 |
| Net Assets | 2,209.00 | 2,148.00 | 2,467.00 | 2,148.00 | 2,129.00 |
| Capital and Reserves | |||||
| Share Capital | 40.00 | 40.00 | 42.00 | 41.00 | 41.00 |
| Share Premium Account | 282.00 | 282.00 | 282.00 | 282.00 | 282.00 |
| Other Reserves | -282.00 | -279.00 | -60.00 | -80.00 | -179.00 |
| Retained Earnings | 2,158.00 | 2,092.00 | 2,189.00 | 1,892.00 | 1,973.00 |
| Shareholders Funds | 2,198.00 | 2,135.00 | 2,453.00 | 2,135.00 | 2,117.00 |
| Minority Interests / Other Equity | 11.00 | 13.00 | 14.00 | 13.00 | 12.00 |
| Total Equity | 2,209.00 | 2,148.00 | 2,467.00 | 2,148.00 | 2,129.00 |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | |
| Operating Margin | 12.77% | 11.20% | 22.80% | 24.73% | 22.34% |
| Return on Capital Employed | 15.82% | 12.25% | 23.84% | 25.95% | 24.55% |
| Dividend Cover | 3.10 | 3.23 | 3.61 | 3.46 | 3.42 |
| Dividend Yield | 3.20 | 2.90 | 1.90 | 1.60 | 1.70 |
| PE Ratio | 10.20 | 10.90 | 14.40 | 18.40 | 16.80 |
| PEG | n/a | n/a | 1.80 | n/a | n/a |
| Dividend per Share Growth | n/a% | -22.22% | -3.57% | -7.41% | -12.00% |
| Net Asset Value per Share | 5.02 USD | 4.63 USD | 7.12 USD | 5.75 USD | 5.86 USD |